Innovotech Inc Total Liabilities

Latest as of June 2026: CA$993.81K CAD ≈ $718.91K USD

Innovotech Inc total liabilities. Based on the latest financial reports, Innovotech Inc (IOT) has total liabilities worth CA$993.81K CAD (≈ $718.91K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Innovotech Inc to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Innovotech Inc (2003–2025)

Total liabilities of Innovotech Inc from 2003 to 2025. This chart illustrates how Innovotech Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Innovotech Inc (IOT) investment intensity to see how much of total assets are deployed in long-term investments.

Innovotech Inc Competitors by Total Liabilities

The table below lists competitors of Innovotech Inc ranked by their total liabilities.

Company Country Total Liabilities
Galore Resources Inc
V:GRI
Canada CA$12.54 Million
Galilee Energy Ltd
AU:GLL
Australia AU$4.94 Million
Playfair Mining Ltd.
V:PLY
Canada CA$180.13K
Kanger International Bhd
KLSE:0170
Malaysia RM36.56 Million
Bluechiip Ltd
AU:BCT
Australia AU$3.94 Million
Golden Goliath Resources Ltd.
V:GNG
Canada CA$389.98K
BCM Alliance Bhd
KLSE:0187
Malaysia RM35.15 Million

Liability Composition Analysis (2003–2025)

This chart breaks down Innovotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Innovotech Inc.

Liquidity & Leverage Metrics

Innovotech Inc Total Liabilities Ratios Explained

Innovotech Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.07 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.39 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.28 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Innovotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Innovotech Inc (2003–2025)

The table below shows the annual total liabilities of Innovotech Inc from 2003 to 2025.

Year Total Liabilities Change
2025-12-31 CA$784.68K
≈ $567.62K
+31.48%
2024-12-31 CA$596.80K
≈ $431.72K
+173.85%
2023-12-31 CA$217.93K
≈ $157.65K
+31.84%
2022-12-31 CA$165.29K
≈ $119.57K
-35.44%
2021-12-31 CA$256.04K
≈ $185.22K
+44.28%
2020-12-31 CA$177.46K
≈ $128.37K
+0.38%
2019-12-31 CA$176.79K
≈ $127.89K
-1.15%
2018-12-31 CA$178.86K
≈ $129.38K
-48.27%
2017-12-31 CA$345.76K
≈ $250.12K
-77.60%
2016-12-31 CA$1.54 Million
≈ $1.12 Million
+26.95%
2015-12-31 CA$1.22 Million
≈ $879.64K
+3.53%
2014-12-31 CA$1.17 Million
≈ $849.63K
+18.33%
2013-12-31 CA$992.54K
≈ $717.99K
+56454.93%
2003-12-31 CA$1.75K
≈ $1.27K
-95.64%
2003-09-30 CA$40.22K
≈ $29.10K
--

About Innovotech Inc

V:IOT Canada Biotechnology
Market Cap
$2.56 Million
CA$3.54 Million CAD
Market Cap Rank
#29735 Global
#1413 in Canada
Share Price
CA$0.07
Change (1 day)
-7.14%
52-Week Range
CA$0.07 - CA$0.29
All Time High
CA$0.34
About

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assa… Read more